Vol 9: Polystyrene-b-polyDL-lactide copolymer-based nanoparticles for anticancer drug delivery.Report as inadecuate



 Vol 9: Polystyrene-b-polyDL-lactide copolymer-based nanoparticles for anticancer drug delivery.


Vol 9: Polystyrene-b-polyDL-lactide copolymer-based nanoparticles for anticancer drug delivery. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 9: Polystyrene-b-polyDL-lactide copolymer-based nanoparticles for anticancer drug delivery.
This article is from International Journal of Nanomedicine, volume 9.AbstractPolystyrene-b-polyDL-lactide PS-PDLLA copolymer-based nanoparticles NPs of a narrow size distribution, negative zeta potential, and spherical shape were fabricated for the delivery of docetaxel DCT. The particle size was consistently maintained in serum for 24 hours and a sustained drug release pattern was observed for 10 days in the tested formulations. The cytotoxicity of the developed blank NPs was negligible in prostate cancer PC-3 cells. Cellular uptake and distribution of the constructed NPs containing a hydrophobic fluorescent dye was monitored by confocal laser scanning microscopy CLSM for 24 hours. Anti-tumor efficacy of the PS-PDLLA-DCT NPs in PC-3 cells was significantly more potent than that of the group treated with commercially available DCT, Taxotere® P



Author: Lee, Jae-Young; Kim, Jung Sun; Cho, Hyun-Jong; Kim, Dae-Duk

Source: https://archive.org/



DOWNLOAD PDF




Related documents